Table 3 Treatment-related toxicities according to WHO toxicity criteria

From: Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer

 

No. of patients (%)

Toxicities

Grade 1

Grade 2

Grade 3

Grade 4

Haematology

 Neutropaenia

9 (22.0)

11 (26.8)

7 (17.1)

4 (9.8)

 Anaemia

12 (29.3)

24 (58.5)

0 (0)

0 (0)

 Thrombocytopaenia

18 (43.9)

7 (17.1)

8 (19.5)

0 (0)

Nonhaematology

 Nausea/vomiting

7 (17.1)

7 (17.1)

9 (22.0)

0 (0)

 Mucositis

5 (12.2)

2 (4.9)

0 (0)

0 (0)

 Diarrhoea

1 (2.4)

2 (4.9)

2 (4.9)

0 (0)

 Gastric ulcer

0 (0)

3 (7.3)

0 (0)

0 (0)

 Duodenal ulcer

0 (0)

2 (4.9)

1 (2.4)

0 (0)

 AST/ALT

3 (7.3)

6 (14.6)

0 (0)

0 (0)

 Neuropathy

0 (0)

1 (2.4)

0 (0)

0 (0)

 Hypersensitivity

3 (7.3)

1 (2.4)

0 (0)

0 (0)

 Infection

1 (2.4)

2 (4.9)

1 (2.4)

0 (0)

  1. ALT=alanine transaminase; AST=aspartate transaminase.